These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 31791278)
1. Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: a real-world experience. Zhang J; Huang Y; Sun Y; He A; Zhou Y; Hu H; Yao Y; Shen Z BMC Cancer; 2019 Dec; 19(1):1168. PubMed ID: 31791278 [TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. Womer RB; West DC; Krailo MD; Dickman PS; Pawel BR; Grier HE; Marcus K; Sailer S; Healey JH; Dormans JP; Weiss AR J Clin Oncol; 2012 Nov; 30(33):4148-54. PubMed ID: 23091096 [TBL] [Abstract][Full Text] [Related]
3. Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide. Lu E; Ryan CW; Bassale S; Lim JY; Davis LE Oncologist; 2020 Feb; 25(2):150-155. PubMed ID: 32043790 [TBL] [Abstract][Full Text] [Related]
6. Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group. Mascarenhas L; Felgenhauer JL; Bond MC; Villaluna D; Femino JD; Laack NN; Ranganathan S; Meyer J; Womer RB; Gorlick R; Krailo MD; Marina N Pediatr Blood Cancer; 2016 Mar; 63(3):493-8. PubMed ID: 26579879 [TBL] [Abstract][Full Text] [Related]
7. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. Granowetter L; Womer R; Devidas M; Krailo M; Wang C; Bernstein M; Marina N; Leavey P; Gebhardt M; Healey J; Shamberger RC; Goorin A; Miser J; Meyer J; Arndt CA; Sailer S; Marcus K; Perlman E; Dickman P; Grier HE J Clin Oncol; 2009 May; 27(15):2536-41. PubMed ID: 19349548 [TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies. Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366 [TBL] [Abstract][Full Text] [Related]
9. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. Kushner BH; Meyers PA J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041 [TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. Le Deley MC; Paulussen M; Lewis I; Brennan B; Ranft A; Whelan J; Le Teuff G; Michon J; Ladenstein R; Marec-Bérard P; van den Berg H; Hjorth L; Wheatley K; Judson I; Juergens H; Craft A; Oberlin O; Dirksen U J Clin Oncol; 2014 Aug; 32(23):2440-8. PubMed ID: 24982464 [TBL] [Abstract][Full Text] [Related]
11. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1. Brunetto AL; Castillo LA; Petrilli AS; Macedo CD; Boldrini E; Costa C; Almeida MT; Kirst D; Rodriguez-Galindo C; Pereira WV; Watanabe FM; Pizza M; Benites E; Morais V; Gadelha A; Nakasato A; Abujamra AL; Gregianin LJ; Pediatr Blood Cancer; 2015 Oct; 62(10):1747-53. PubMed ID: 25917418 [TBL] [Abstract][Full Text] [Related]
12. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience. Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446 [TBL] [Abstract][Full Text] [Related]
13. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014 [TBL] [Abstract][Full Text] [Related]
14. Challenges in the management of localized Ewing sarcoma in a developing country. Totadri S; Bansal D; Rao KLN; Jain R; Saxena AK; Kapoor R; Samujh R; Trehan A Pediatr Hematol Oncol; 2020 Oct; 37(7):610-619. PubMed ID: 32558608 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli. Bacci G; Ferrari S; Bertoni F; Donati D; Bacchini P; Longhi A; Brach Del Prever A; Forni C; Rimondini S J Clin Oncol; 2000 Feb; 18(4):885-92. PubMed ID: 10673532 [TBL] [Abstract][Full Text] [Related]
16. Vincristine, doxorubicin, cyclophosfamide, actinomycin D, ifosfamide, and etoposide in adult and pediatric patients with nonmetastatic Ewing sarcoma. Final results of a monoinstitutional study. Ferrari S; Palmerini E; Alberghini M; Staals E; Mercuri M; Barbieri E; Longhi A; Cantero L; Cesari M; Abate M; Balladelli A; Picci P; Bacci G Tumori; 2010; 96(2):213-8. PubMed ID: 20572576 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor. Laurence V; Pierga JY; Barthier S; Babinet A; Alapetite C; Palangié T; de Pinieux G; Anract P; Pouillart P Am J Clin Oncol; 2005 Jun; 28(3):301-9. PubMed ID: 15923805 [TBL] [Abstract][Full Text] [Related]
18. Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial. Brennan B; Kirton L; Marec-Bérard P; Gaspar N; Laurence V; Martín-Broto J; Sastre A; Gelderblom H; Owens C; Fenwick N; Strauss S; Moroz V; Whelan J; Wheatley K Lancet; 2022 Oct; 400(10362):1513-1521. PubMed ID: 36522207 [TBL] [Abstract][Full Text] [Related]
19. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies. Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153 [TBL] [Abstract][Full Text] [Related]
20. International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol. Anderton J; Moroz V; Marec-Bérard P; Gaspar N; Laurence V; Martín-Broto J; Sastre A; Gelderblom H; Owens C; Kaiser S; Fernández-Pinto M; Fenwick N; Evans A; Strauss S; Whelan J; Wheatley K; Brennan B Trials; 2020 Jan; 21(1):96. PubMed ID: 31952545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]